(1 - 17 from 17
)
In Profile: Thomas Muehlbauer, CEO, founder, Avacen Medical - Medical...
www.medicalplasticsnews.com
Thomas Muehlbauer talks to MPN about Avacen Medical and Advanced Vascular Circulation Enhancement
Avacen, Inc. - July 25, | FDANews
www.fdanews.com
Procedures for quality audits have not been established.
Company News - Biotechgate
www.koreanbiotech.com
According to Thomas G. Muehlbauer, CEO of AVACEN Medical, "Our patented AVACEN Treatment Method is an entirely new concept in microcirculation therapy.
sorted by relevance / date